Background
Introduction
Stem cell therapy has the potential to play an important role in regenerative medicine. Mesenchymal stromal/stem cells (MSC) have been extensively investigated for clinical application over the past decade. [1, 2] MSC are capable of differentiating into a variety of important tissues, such as: bone, cartilage and adipose. [3] They also display immunomodulatory properties. [4] [5] [6] Their presence in adult tissue, and ease of expansion in vitro has made MSC good candidate cells for clinical translation. [7, 8] In order to advance stem cell therapy, tools must be developed to monitor the survival of implanted stem cells non-invasively after administration to the patient. Magnetic resonance imaging (MRI) cell tracking is an effective method to visualize and monitor cells non-invasively after implantation due to the high spatial resolution and lack of ionizing radiation.
The majority of MRI cell tracking studies have used iron oxide nanoparticles to label the cells of interest. [9] [10] [11] [12] [13] [14] [15] When imaged with MRI, the iron nanoparticles produce a dark signal void in T2/T2
Ã weighted proton images. This technique is highly sensitive, permitting the imaging of single cells. [16, 17] Limitations with tracking iron-labeled cells arise from low specificity, due to other regions in the image with low signal, and from complicated in vivo quantification of the signal loss. Our group and others have shown that degree of signal loss produced by iron labeled cells is only linear at low iron concentrations. [16, 18] Furthermore the high sensitivity to iron can produce ambiguity due to the strong false-positive signal produced when even a small number of bystander cells become labeled inadvertantly. [19, 20] As an alternative to iron cell tracking, fluorine-19 ( 19 F) MRI with perfluorocarbon (PFC) nanoemulsions has been used for cell tracking. [21] 19 F MRI is able to image implanted cells with high specificity due to the lack of detectable fluorine in biological tissue. [22, 23] Quantification of implanted cells is possible since the 19 F MRI signal intensity is linearly related to the number of 19 F-labeled cells. Unlike PET/SPECT probes, 19 F does not undergo radioactive decay allowing for longitudinal studies without radiation-induced toxicity to the implanted cells or surrounding tissue. Furthermore, the first clinical application of 19 F-MRI cell tracking for DC immunotherapy was recently reported, showing the technique is both feasible and safe for human application. [24] In this paper, we investigated the feasibility of quantifying MSC survival in two different immune system environments. This was performed by comparing the change in 19 F-MRI signal strength over time using two popular transplantation models. A syngeneic transplant model, with mouse MSC (mMSC) implanted in an immune-competent mouse host, was compared to a xenograft model produced from human MSC (hMSC) implanted in an immunecompromised mouse. Our goals were: i) to quantify the apparent cell number non-invasively for 2.5 weeks and ii) to validate in vivo 19 F-MRI quantification results with fluorescence microscopy and immunohistochemistry.
Methods

MSC culture and labeling
hMSC came from bone marrow donated by healthy young adult volunteers after written informed consent according to a protocol approved by University Health Network Research Ethics Board (Toronto, Canada) [25] . hMSC were cultured as described by Ribot et al. [19] mMSC derived from the bone marrow of C57Bl/6 mice and expressing green fluorescence protein (GFP+) were purchased from Cyagen Bioscience Inc. (Catalog # MUBMX-01101). The cells were cultured in OriCell Mouse MSC Growth Medium until 90% confluent. The mMSC were passaged once before labeling and implantation.
All MSC were labeled with the red fluorescent perfluoropolyether agent, Cell Sense (CS-ATM-DM Red; CelSense Inc. Pittsburg, USA) [26] . Labeling took place over 24 hours at a concentration of 2.5mg/mL. After incubation, the cells were washed 3 times with Hank's balanced salt solution (HBSS), harvested with Trypsin, spun down and counted. At this stage the cells were tested for viability using trypan blue exclusion. Intracellular 19 F content of cells was determined using NMR spectroscopy, as we have described previously. [19] MSC implantation 1.5x10 6 Cell Sense-labeled hMSC in 100μL of HBSS were implanted intramuscularly into the right hindlimb muscle of immune-compromised, nude mice (nu/nu, Charles River Canada) to produce a xenograft model (n = 7). In a similar manner, 2.0x10 6 labeled mMSC in 100μL of HBSS were implanted into immune competent, C57Bl/6 mice (Jackson Laboratories) producing a syngeneic model (n = 8). In both cases, the injections were performed under 2% isoflurane anesthesia. All experiments involving human and mouse stem cells, as well as animal use, were approved by the Western University Animal Use Committee (AUP 2009-042).
MRI
All images were collected using a 9.4T Varian small-animal MRI scanner. A 3D balanced steady state free precession (bSSFP) sequence was used for both proton and fluorine imaging. Cell pellets containing 2x10 5 , 4x10 5 , 6x10 5 , 8x10 5 , 1x10 6 and 2x10 6 19 F-labeled MSC were imaged alongside a reference tube of known fluorine concentration (7.3x10 16 19 F/μL). MRI was performed using a dual-tuned birdcage volume coil (diameter 2.2cm, length 5.1cm), tuned to 400.2 MHz and 376.8 MHz for proton and fluorine imaging respectively. For proton imaging of cell pellets the scan parameters were: repetition time (TR) = 3.8ms, echo time (TE) = 1.9ms, receiver bandwidth (rBW) = 125kHz, flip angle (FA) = 30°, averages = 2, resolution = 200x200x200μm 3 . For fluorine imaging the parameters were: TR = 3.5ms, TE = 1.8ms, rBW = 25kHz, FA = 70°, averages = 250, resolution = 1x1x2mm 3 . Total protocol time for both proton and fluorine imaging was under 90 minutes. The pellets were imaged on three separate occasions to test quantification variability. Mice containing 19 F-labeled MSC implantations were imaged at four time points, starting on day 0, after implantation. The scan parameters were the same for the in vivo mouse MRI as described previously. During scanning the mice were anesthetized with 2% isoflurane, with breathing rate and temperature monitored. Due to the high sensitivity of bSSFP to offresonance frequencies [27] , a narrow 1.5kHz sinc pulse was used to excite only the 19 F agent.
Image analysis and quantification
Prior to image analysis, a signal correction was applied to the 19 F datasets by subtracting a constant value (x) from all voxels within the dataset using the image program, ImageJ. [28, 29] The value of x was equal to the signal of the single voxel containing the lowest signal throughout the entire dataset. This linear translation acted to left-shift the data distribution to begin at zero. Quantification was performed using Voxel Tracker software, as described by Srinivas et al. [30] Briefly, in the 19 F MR images, the signal contained within a hand drawn ROI is summed and compared to the average signal produced by the reference tube of known concentration (2.6x10 16 19 F spins/μL). This value (X) provides the total number of 19 F spins located at the ROI. NMR spectroscopy was then performed using a known number of the same transplanted cells, along with a second 19 F source containing a known number of 19 
Immunohistochemistry
Mice were sacrificed and perfused with 4% paraformaldehyde following the final imaging timepoint. In addition, one mouse from each model was sacrificed and perfused on Day 0 for comparison. The hindlimb muscle was extracted and cryoprotected with increasing concentrations of sucrose (10%, 20%, 30%) before freezing in OCT medium. Tissue was sectioned with a cryostat. Fluorescence microscopy was performed to image the red fluorescent 19 F-label as well as the GFP+ mMSC with a Zeiss AXIO Imager microscope (Carl Zeiss Canada Ltd). Immunohistochemistry staining was then performed on these sections. Macrophage presence was assessed using Biotin anti-mouse macrophage (F4/80) monoclonal antibody (Cedarlane Laboratories Ltd) with 3,3'-Diaminobenzidine (DAB) counterstain. Quantification of 19 
Results
Labeling of MSC with Cell Sense
F in cell samples
Quantification of the 19 F signal was tested in vitro using Cell Sense labeled mMSC pellets. Imaging was performed at 9.4T on six cell pellets ranging from 200k to 2 million cells. Fig. 2 represents the average quantification and standard deviation from imaging the cell pellets on three different occasions. We observed a strong linear relationship between the MR quantification and the real cell number, with an R 2 = 0.98.
In vivo detection of 19 F MRI signal 19 F-MRI signal was initially detectable in all mice following intramuscular injection of 2.0x10 6 mMSC or 1.5x10 6 hMSC. On day 0 quantification of the in vivo signal agreed very well with the number of implanted cells (Fig. 3) . Over time the signal decreased in both models. In the immune competent model (Fig. 3A) , a significant effect was observed in the decrease in 19 Representative MR image data, fluorescence microscopy, and H&E obtained on day 0 is shown in Fig. 4 . Overlays of the 19 F MRI onto the proton image at day 0 are show in 4A and E for the immune competent and immune compromised mice respectively. Fig. 4B and F show that the red fluorescence signal from the 19 F labeling agent can be detected on day 0 in both models. The green fluorescence associated with the GFP+ mMSC was also clearly visible at the site of their implantation on day 0 (Fig. 4C) . Overlaying the two fluorescent images revealed strong co-localization, with a Pearson's correlation coefficient of 0.80, between the red fluorescent 19 F agent and the GFP+ mMSC in Fig. 4D . The corresponding H&E stained tissue sections reveal the location of the implant within the muscle (Fig. 4G,H ). Fig. 5 shows representative MR image data, H&E, F4/80 immunohistochemistry and fluorescence microscopy obtained at the experimental endpoint. By day 16 post implantation no 19 F signal from the mMSC was detectable in 5/7 of the immune competent mice. One of these mice is shown in Fig. 5A where the only 19 F signal comes from the reference tube. In contrast, 19 F signal was still detectable in all of the immune compromised mice at day 17, an example is shown in Fig. 5E .
Fluorescence microscopy revealed only a small area of red fluorescence from the 19 F agent in the immune competent model (Fig. 5B ) compared to the immune compromised (Fig. 5F ).
In addition, no GFP+ mMSC were detectable in ex vivo samples at endpoint. H&E staining of the same tissue sections clearly showed cells at the site of the implant, which strongly corresponded with the 19 F agent's red fluorescence (Fig. 5C,G) . Neighboring tissue sections corresponding to high red fluorescence were stained for the presence of macrophages using F4/80. Fig. 5D shows that relatively few macrophages were detected in the immune competent model An important additional finding worth noting was that 19 F signal due to the use of inhalational isoflurane anesthesia could be eliminated by using a narrow 1.5 kHz sinc excitation pulse. S1 Fig. shows that a broader 3kHz RF pulse led to substantial background 19 F signal in the mouse body. Isoflurane becomes concentrated within fat pads during imaging [31] and these high levels of 19 F signal can lead to false-positive detection and incorrect quantification. 6 hMSC. 19 F signal was found to decrease at a slower rate, with observable signal in all mice at endpoint. Statistical significance is denoted in the same way as A. Isoflurane anesthesia is preferred for the ease of use and the relatively long imaging times required for 19 F MRI. Another option is ketamine/xylazine but this requires the use of an intravenous or intraperitoneal catheter and infusion pump in order to maintain effectiveness over the time period required which can be challenging in mice. [32] [33] [34] Pentobarbital is also capable of providing anesthetic for over 2 hours [19] , but its use leads to a high mortality rate in experimental animals.
Discussion
In vivo quantification of MSC
This study demonstrates the ability to use 19 F-MRI cell tracking to detect and, most importantly, to measure the number of transplanted stem cells in vivo. Cell number cannot be quantified using other MRI cell tracking techniques. Numerous studies have reported on the challenges associated with quantification of signal loss due to iron-labeled cells. [19, 20, 35] This has, so far, narrowed the implementation of cell tracking for monitoring the fate of transplanted cells. In this study we show excellent correlation between the number of labeled cells implanted and the number of cells counted on day 0 by 19 F-MRI. This capability will pave the way for MRI to be used for to confirm the delivery of therapeutic cell transplants. The importance of accurate delivery of cells to a target tissue cannot be overstated. In preclinical investigations often stem cells will be transplanted then a set time allowed to lapse before the transplanted tissue is removed and processed for microscopy, to determine whether stem cells remain in the tissue. In many cases only a very small sample of the transplanted tissue is evaluated. In a previous study we used MRI to track iron-labeled MSC in a mouse model of spinal cord injury [36] . Our in vivo imaging revealed that the challenging intrathecal injections of MSC were imprecise approximately 25% of the time; injected cells were often being deposited in tissue above the cord or leaking out of the cord. The histological assessment in this study involved the analysis of 1cm of cord tissue on either side of the transplant site, six weeks after transplantation. Without MRI, a negative observation of MSC by microscopy would have been taken as failure to engraft rather than due to a missed injection. Injection confirmation with 19 F MRI would have the additional advantage of determining how many cells were properly injected and remain at the site.
In a first-in-man study, MRI and scintigraphy were used to assess the success of intranodal injections consisting of a 1:1 mixture of iron-or indium-labeled dendritic cell (DC) for cancer therapy in melanoma patients. [37] Despite these cell injections being performed under ultrasound guidance the MRI of iron-labeled DC revealed that in 3/8 cases DC were injected near, but not in, the target lymph nodes. [37] These findings make it clear that the outcome of this cell therapy on these patients would not be properly evaluated without knowledge of proper delivery of DC to the nodes. For DC therapy knowledge of the number of cells delivered to a lymph node is especially critical since DC migration to nodes correlates with effective stimulation of T cells. 19 F-MRI therefore presents a promising solution to the clinical problem of verifying both the location and number of cells within the region of interest immediately following administration of treatment.
In these experiments the hMSC and the mMSC were both capable of taking up sufficient 19 F label for in vivo detection, without decreasing viability below 80%. We observed some variation in the number of 19 
Monitoring the fate of MSC over time
This study also revealed some interesting information about tracking cell fate over time with 19 F MRI. We studied the fate of MSC in two different models: mMSC implanted into healthy wild type C57Bl/6 mice (immune competent model) and hMSC implanted into healthy nude mice (immune compromised model). The MSC underwent clearance from the sites of implantation in muscle at different rates, which is not unexpected since the two different mouse strains have very different immune systems.
In the immune competent model, 5/7 mice had no MRI detectable 19 F signal remaining at the site of injection by the endpoint. The other 2 mice had just 4% and 10% of the original signal remaining. There were no GFP+ cells detected by fluorescence microscopy but there was some red fluorescence, indicating that some of the 19 F label persisted at the site but that it was not within GFP+ mMSC. The small amount of residual red fluorescent signal corresponded with F4/80 staining suggesting that some transfer of 19 F label from mMSC to macrophages has occurred. The decline in the signal is likely the result of a number of different things happening at the transplant site. First, a large number of MSC will die early after their direct transplantation into a tissue. Second, the label may be diluted by MSC proliferation, or degradation of the label within MSC. Third, MSC may have migrated away from the implant site; although we did not detect 19 F signal in other nearby locations.
The fact that for 5/7 mice no MRI signal was detected, even though red fluorescence was still observed in the tissues (as for the example shown in Fig. 5A-D) is most likely because the number of cells containing the red fluorescent 19 F label is very small and this small amount of 19 F signal is below the in vivo detection limits of the MRI protocols used in this study.
In the immune compromised model the 19 F signal persisted in all mice until the experimental endpoint. Much more red fluorescence was observed in these tissues at the implant site and this corresponded well with F4/80 staining, again suggesting that the persistent 19 F signal was related to transfer of label from hMSC to macrophages. A limitation of this study was that our hMSC were not also GFP+. This would have allowed us to say with more confidence that the 19 F label was associated with macrophages and not the implanted hMSC. Clearance of label and macrophages may have been slower in these mice because of the inhibited immune system and lack of rejection response.
Our observation of bystander cell uptake of 19 F cell label is supported by a study by BoehmSturm et al. [38] In their study in vivo imaging of the location, density, and survival of neural stem cells implanted in the brain in a stroke model was performed using 19 F MRI in combination with bioluminescence imaging. The signal from 19 F labeled stem cells persisted for more than 4 weeks after implantation while, over the same time period, the bioluminescence declined, indicating stem cell death. Immunohistochemistry staining also revealed the presence of microglia/macrophages at the site of implantation. Terrovitis et al. looked at the retention of iron labeled stem cells implanted into immune competent rats. [20] Either rat or human cardiac-derived stem cells were injected intramyocardially. In both cases MRI signal loss due to iron was detected for 3 weeks post cell injection and correlated with the presence of iron containing macrophages in histology. Although the area of signal void decreased over time substantial signal void persisted at the injection site in all mice. Since proton MRI is sensitive to even small numbers of iron-labeled cells this form of cell tracking is most susceptible to the misinterpretation of cell fate. Previous studies performed in our lab using iron labeled syngeneic MSC also revealed the persistence of an iron signal void past 21 days in immune competent mice. [14] 
Conclusion
In summary, 19 The non-filtered sinc pulse width is much broader with a FWHM of 1.32ms in time space. This produces a narrower pulse in frequency space, preventing the excitation of isoflurane signal.
